Home
About BEB
Curriculum
Admission
CNC Research
BEB in the Media
 
 
PRINCIPLES AND PRACTICE IN DRUG DEVELOPMENT - ELECTIVE COURSE
 
April 7 - 17
João Nuno Moreira (jmoreira@ff.uc.pt)
MIT-PORTUGAL PROGRAM 2014/2015
PRINCIPLES AND PRACTICE IN DRUG DEVELOPMENT - ELECTIVE COURSE
Center for Neuroscience and Cell Biology (CNC) - University of Coimbra

April 7 - April 17, 2015

João Nuno Moreira, Luís Pereira de Almeida, Sérgio Simões, Stan Finkelstein

Local: CNC auditorium (Polo 1)


April 7 - Tuesday
10.00 h - Introduction to the course
João Nuno Moreira - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Luís Pereira de Almeida - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Sérgio Simões - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Stan N. Finkelstein - MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)


11.00 h - The Pharmaceutical Industry and the Drug Development Process
Stan N. Finkelstein - MD, PhD (Senior Research Scientist in the MIT Engineering Systems Division and Associate Professor of Medicine, Harvard Medical School)

14.00 h - Building predictive oncology models
Darrin Stuart - PhD (Senior Investigator II, Novartis Institutes for Biomedical Research (USA)

16.00 h - Basic Science I – Discovery Innovation and Emerging Technologies; Basic Business
Anthony J. Sinskey - PhD (Professor of Biology at MIT)


April 8 - Wednesday
10.00 h - Modeling chemistry and biology in drug discovery
Nuno Palma - PhD (BIAL, Indústria Farmacêutica, Portugal)

11.30 h - Development of small molecule inhibitors for treatment of CNS disorders
Laszlo Kiss - PhD (BIAL, Indústria Farmacêutica, Portugal)


14.30 h - Pharmacology and toxicology of new chemical entities
Lyndon C. Wright - PhD (BIAL, Indústria Farmacêutica, Portugal)

16:00 h - Clinical development of new chemical entities
José Francisco - BSc (BIAL, Indústria Farmacêutica, Portugal)


April 9 - Thursday
10.00 h - FDA Process, Off-Label Prescribing, Insurance Coverage
Stan N. Finkelstein - MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)

14.00 h - Title to be announced
Guy Villax - CEO (Hovione, Portugal)


16.30 h - Technology transfer – the perspective from MIT
Aaron D Schwartz - Licensing officer at the MIT TLO

April 10 - Friday
10.00 h - Regulatory Affairs – the european perspective
Rogério Gaspar - PhD (iMed.UL and Faculty of Pharmacy, University of Lisbon)

14.00 h - The Role of Quality by Design in the Pharmaceutical Industry
Filipe Gaspar - PhD (Vice-President for R&D, Hovione, Portugal)


April 13 – Monday
09.00 h - The drug discovery process
Peter Høngaard Andersen, PhD (CEO of Innovation Fund Denmark)

16.00 h - Building Merrimack Therapeutics
Robert Mulroy - CEO of Merrimack Therapeutics


April 14 - Tuesday
9.30 h - Nanotechnology for drug targeting and the impact on drug development
João Nuno Moreira - PhD
Vera Moura - PhD (CEO of TREAT U, SA and CNC)
Nuno Fonseca  - MSc (CNC and TREAT U, SA )

14.00 h - Visit to Biocant Park – Innovation Center in Biotechnology


April 15 - Wednesday
9.30 h - Bluepharma Pharmaceutical Industry SA: from development of generics to innovative research - site visit


14.30 h - Nanotechnology for drug and gene targeting and the impact on drug development (cont.)
Sérgio Simões - PhD
Luís Pereira de Almeida - PhD


April 16 - Thursday
10.00 h - Some issues in drug development: discussion of case studies
Miguel Prazeres - PhD (Instituto Superior Técnico, Technical University of Lisbon)

16.00 h - Basic science and clinical development of a gene replacement therapy
Mark Goldberg - MD, PhD (Harvard Medical School)


April 17 – Friday
9 h - Students presentations
back
 
© 2017 BEB - Doctoral Programme in Experimental Biology and Biomedicine powered by ponto.C